Q1 2025 Sanara Medtech Inc Earnings Call Transcript
Key Points
- Sanara MedTech Inc (SMTI) reported a 26% year-over-year increase in net revenue for the first quarter of 2025, driven by strong sales of soft tissue repair products.
- The company achieved a 30% increase in gross profit, with gross margins improving by 240 basis points to 92% of net revenue.
- Sanara MedTech Inc (SMTI) expanded its distributor network significantly, securing agreements with over 400 distributor partners, enhancing sales coverage across the US.
- The launch of the THP technology platform, including the THP Co-pilot app, marks a pivotal milestone in the company's strategy to disrupt non-acute wound care.
- Sanara MedTech Inc (SMTI) has secured distribution rights to two additional technologies, enhancing its product pipeline and growth potential.
- Operating expenses increased by 30% to $23.7 million, driven by higher selling, general, and administrative expenses.
- The company reported a net loss of $3.5 million for the first quarter, compared to a net loss of $1.8 million in the previous year.
- The Tissue Health Plus segment generated a net loss of $2.9 million, an increase from a net loss of $1.4 million last year.
- Interest expenses and fees related to the CRG term loan contributed to an increase in other expenses, totaling $1.4 million for the quarter.
- Despite revenue growth, the Sanara surgical segment still reported a net loss of $0.6 million, up from a net loss of $0.4 million last year.
Welcome to the Sanara MedTech first quarter of 2025 earnings conference call. Please note that this conference call is being recorded, and a replay will be available on the investor relations page of the company's website shortly. The company issued its earnings release earlier today.
Before we begin, I would like to remind everyone that certain statements on today's call include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1,995.
For more information about the risks and uncertainties involving forward-looking statements and factors that could cause actual results to differ materially from those projected or implied by forward-looking statements, please see the risk factors set forth in the company's most recent annual report on Form 10k.
This call will also include references to certain non-GAAP measures, reconciliations of those non-GAAP financial measures to the most comparable measures calculated and presented in accordance with GAAP are available in the earnings materials available on the investor relations portion of our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
